Aptadel Therapeutics

Aptadel Therapeutics

A biotech company focused on the development of cancer treatment based on aptamer technology.

Launch date
Employees
Market cap
-
Enterprise valuation
€7—10m (Dealroom.co estimates Jan 2021.)
Company register number B02925824
Barcelona Catalonia (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout

€1.7m

Seed
Total Funding€1.7m

Recent News about Aptadel Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.